Get Started

BLRX

NASD BioLineRX Ltd. Sponsored ADR
Nov 4, 2026 · 9:56 PM ET EOD Market Closed

$1.86 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.86, $0.06 below the day’s high of $1.92

YTD change
-32.85%
vs 20-day SMA
-10.22%
vs 200-day SMA
-31.88%

Price ranges

Previous day
$1.90 $1.99
open $1.94 close $1.91
-$0.03 (-1.55%)
Today
$1.81 $1.92
open $1.81 now $1.86
+$0.05 (+2.76%)
Past week
$1.90 $2.04
from $2.03 now $1.86
-$0.17 (-8.37%)
Past month
$1.90 $2.37
from $2.29 now $1.86
-$0.43 (-18.86%)
This year
$1.81 $3.95
from $2.77 now $1.86
-$0.91 (-32.85%)

Price & Performance

-1.18 (-38.82%) / 6M

$1.71$2.45$3.19$3.93May 4Aug 5Nov 4

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.8% away from all-time highs of $1,103.94
  • BLRX is down 33% since the beginning of the year
  • BLRX is down 44% over the past 12 months
  • BLRX is down 19% over the past 1 month
  • 2% of all BLRX investors are betting against BLRX

BLRX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -43.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum +100.0% Quarterly EPS growth
Quarterly change +100.0%

Valuation

P/E ratio N/A
Enterprise value $6.2M
Beta 2.47

Balance sheet & scale

IncomeN/A
Revenue$1.4M
Cash$13.1M
Debt$7.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $10.6M

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,417.99 +0.61%
JNJ Johnson & Johnson $276.32 +3.81%
ABBV AbbVie, Inc. $294.83 +3.09%
MRK Merck & Co., Inc. $150.36 +3.93%
RHHBY Roche Holding Ltd Sponsored ADR $60.94 +2.97%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.